CAMPTO Side Effects

5806444-5 | Angioedema
on Jul 03, 2008 Male patient from FRANCE , weighting 152.1 lb, was diagnosed with colon cancer and was treated with Campto (View Usage). Patient experienced the following unwanted or unexpected effects: angioedema. Campto dosage: . During the same period patient was treated with FOLINIC ACID (View Folinic Acid Review and Folinic Acid Label ). Patient was hospitalized.

5799404-4 | Central Nervous System Lesion, Cerebral Microangiopathy, Confusional State, Dementia, Incontinence, Memory Impairment, Polyneuropathy
Patient was taking Campto (View Usage). Patient had the following side effects: central nervous system lesion, cerebral microangiopathy, confusional state, dementia (What is dementia?), incontinence, memory impairment, polyneuropathy on Jun 27, 2008 from GERMANY Additional patient health information: Male patient , weighting 242.5 lb, was diagnosed with colon cancer and. Campto dosage: Daily Dose:180mg-freq:every 14 Days. During the same period patient was treated with BEVACIZUMAB (Freq:every 14 Dats) (View Bevacizumab Review and Bevacizumab Label ), FLUOROURACIL (Daily Dose:2400mg-freq:every 14 Days) (View Fluorouracil Review and Fluorouracil Label ).

5799270-7 | Diarrhoea, Stevens-johnson Syndrome
Adverse event was reported on Jun 24, 2008 by a Male patient taking Campto (View Usage) (Dosage: Daily Dose:100mg) was diagnosed with rectal cancer, nausea (What is nausea?), diabetes mellitus, gastric ulcer, anaemia and. Location: JAPAN , weighting 114.6 lb, After Campto was administered, patient had the following side effects: diarrhoea, stevens-johnson syndrome. During the same period patient was treated with TEGAFUR/GIMERACIL/OTERACIL POTASSIUM (Daily Dose:100mg) (View Tegafur/gimeracil/oteracil Potassium Review and Tegafur/gimeracil/oteracil Potassium Label ), PREDONINE (Daily Dose:45mg) (View Predonine Review and Predonine Label ), GRANISETRON HCL (Text:1 Df) (View Granisetron Hcl Review and Granisetron Hcl Label ), DECADRON (Daily Dose:8mg) (View Decadron Review and Decadron Label ), AMARYL (Daily Dose:1mg) (View Amaryl Review and Amaryl Label ), TAKEPRON (Daily Dose:15mg) (View Takepron Review and Takepron Label ), FERROMIA (Daily Dose:100mg) (View Ferromia Review and Ferromia Label ), SOLU MEDROL (Daily Dose:500mg) (View Solu-medrol Review and Solu-medrol Label ).

5794271-7 | Confusional State, Renal Failure
on Jun 18, 2008 Female patient from FRANCE , 76 years of age, was diagnosed with rectal cancer metastatic, metastases to liver and was treated with Campto (View Usage). Patient experienced the following unwanted or unexpected effects: confusional state, renal failure. Campto dosage: . During the same period patient was treated with LARGACTIL (View Largactil Review and Largactil Label ), PRIMPERAN TAB (View Primperan Tab Review and Primperan Tab Label ), ZOPHREN (View Zophren Review and Zophren Label ), FLUOROURACIL (Freq:cyclic) (View Fluorouracil Review and Fluorouracil Label ), ATROPINE SULFATE (View Atropine Sulfate Review and Atropine Sulfate Label ), RABEPRAZOLE SODIUM (Daily Dose:20mg) (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ).


5788311-9 | Gastrointestinal Haemorrhage, Haemoglobin Decreased, Hepatic Encephalopathy, Hepatitis B, Hepatitis Fulminant, Leukopenia, Neutropenia
on Jun 13, 2008 Male patient from JAPAN , weighting 119.0 lb, was diagnosed with rectal cancer and was treated with Campto (View Usage). Patient had the following side effects: gastrointestinal haemorrhage, haemoglobin decreased, hepatic encephalopathy, hepatitis b (What is hepatitis b?), hepatitis fulminant, leukopenia, neutropenia. Campto dosage: Daily Dose:90mg. During the same period patient was treated with BRIPLATIN (Daily Dose:90mg) (View Briplatin Review and Briplatin Label ). Patient was hospitalized.

5777790-9 | Stevens-johnson Syndrome
Patient was taking Campto (View Usage). After Campto was administered, patient had the following side effects: stevens-johnson syndrome on Jun 06, 2008 from JAPAN Additional patient health information: Male patient , 71 years of age, was diagnosed with rectal cancer and. Campto dosage: . During the same period patient was treated with TEGAFUR/GIMERACIL/OTERACIL POTASSIUM (Daily Dose:100mg) (View Tegafur/gimeracil/oteracil Potassium Review and Tegafur/gimeracil/oteracil Potassium Label ). Patient was hospitalized.

5754263-0 | Hepatitis B, Leukopenia, Neutropenia
Adverse event was reported on May 16, 2008 by a Male patient taking Campto (View Usage) (Dosage: Daily Dose:90mg) was diagnosed with rectal cancer and. Location: JAPAN , weighting 119.0 lb, Patient experienced the following unwanted or unexpected effects: hepatitis b (What is hepatitis b?), leukopenia, neutropenia. During the same period patient was treated with BRIPLATIN (Daily Dose:90mg) (View Briplatin Review and Briplatin Label ). Patient was hospitalized.

5740717-X | Blister, Rash
on May 08, 2008 Male patient from NETHERLANDS , weighting 191.8 lb, was diagnosed with colon cancer metastatic, prophylaxis and was treated with Campto (View Usage). Patient had the following side effects: blister, rash (What is rash?). Campto dosage: . During the same period patient was treated with TAVEGYL (View Tavegyl Review and Tavegyl Label ).

5724428-2 | Eczema
on Apr 23, 2008 Female patient from FRANCE , 77 years of age, was diagnosed with colon cancer and was treated with Campto (View Usage). After Campto was administered, patient had the following side effects: eczema (What is eczema?). Campto dosage: . During the same period patient was treated with CETUXIMAB (View Cetuximab Review and Cetuximab Label ).

5711650-4 | Diarrhoea, Hyperkalaemia, White Blood Cell Count Decreased
Patient was taking Campto (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, hyperkalaemia, white blood cell count decreased on Mar 28, 2008 from JAPAN Additional patient health information: Male patient , weighting 108.0 lb, was diagnosed with gastric cancer, constipation (What is constipation?), congestive cardiomyopathy, prophylaxis against gastrointestinal ulcer and. Campto dosage: . During the same period patient was treated with TEGAFUR/GIMERACIL/OTERACIL POTASSIUM (View Tegafur/gimeracil/oteracil Potassium Review and Tegafur/gimeracil/oteracil Potassium Label ), TELEMINSOFT (Daily Dose:10mg) (View Teleminsoft Review and Teleminsoft Label ), DIGOXIN (Daily Dose:.125mg) (View Digoxin Review and Digoxin Label ), LASIX (Daily Dose:40mg) (View Lasix Review and Lasix Label ), ALDACTONE (Daily Dose:25mg) (View Aldactone Review and Aldactone Label ), FAMOTIDINE (Daily Dose:40mg) (View Famotidine Review and Famotidine Label ). Patient was hospitalized.

5706005-2 | Diarrhoea, Hyperkalaemia
Adverse event was reported on Mar 28, 2008 by a Male patient taking Campto (View Usage) (Dosage: ) was diagnosed with gastric cancer, constipation (What is constipation?), congestive cardiomyopathy, prophylaxis against gastrointestinal ulcer and. Location: JAPAN , weighting 108.0 lb, Patient had the following side effects: diarrhoea, hyperkalaemia. During the same period patient was treated with TEGAFUR/GIMERACIL/OTERACIL POTASSIUM (View Tegafur/gimeracil/oteracil Potassium Review and Tegafur/gimeracil/oteracil Potassium Label ), TELEMINSOFT (Daily Dose:10mg) (View Teleminsoft Review and Teleminsoft Label ), DIGOXIN (Daily Dose:.125mg) (View Digoxin Review and Digoxin Label ), LASIX (Daily Dose:40mg) (View Lasix Review and Lasix Label ), ALDACTONE (Daily Dose:25mg) (View Aldactone Review and Aldactone Label ), FAMOTIDINE (Daily Dose:40mg) (View Famotidine Review and Famotidine Label ). Patient was hospitalized.

5703959-5 | Diarrhoea, Hyperkalaemia
on Mar 28, 2008 Male patient from JAPAN , weighting 108.0 lb, was diagnosed with gastric cancer, ill-defined disorder, congestive cardiomyopathy and was treated with Campto (View Usage). After Campto was administered, patient had the following side effects: diarrhoea, hyperkalaemia. Campto dosage: . During the same period patient was treated with TEGAFUR/GIMERACIL/OTERACIL POTASSIUM (View Tegafur/gimeracil/oteracil Potassium Review and Tegafur/gimeracil/oteracil Potassium Label ), BISACODYL (Daily Dose:10mg) (View Bisacodyl Review and Bisacodyl Label ), DIGOXIN (Daily Dose:.125mg) (View Digoxin Review and Digoxin Label ), LASIX (Daily Dose:40mg) (View Lasix Review and Lasix Label ), ALDACTONE (Daily Dose:25mg) (View Aldactone Review and Aldactone Label ), FAMOTIDINE (Daily Dose:40mg) (View Famotidine Review and Famotidine Label ). Patient was hospitalized.

5703086-7 | Haemoglobin Decreased, Hyperkalaemia, Ileus Paralytic, Neutropenia
on Mar 31, 2008 Male patient from JAPAN , weighting 121.3 lb, was diagnosed with gastric cancer, prophylaxis of nausea and vomiting and was treated with Campto (View Usage). Patient experienced the following unwanted or unexpected effects: haemoglobin decreased, hyperkalaemia, ileus paralytic, neutropenia. Campto dosage: Daily Dose:126mg. During the same period patient was treated with TEGAFUR/GIMERACIL/OTERACIL POTASSIUM (View Tegafur/gimeracil/oteracil Potassium Review and Tegafur/gimeracil/oteracil Potassium Label ), KYTRIL (View Kytril Review and Kytril Label ), DECADRON (View Decadron Review and Decadron Label ). Patient was hospitalized.

5700520-3 | Neutrophil Count Decreased
Patient was taking Campto (View Usage). Patient had the following side effects: neutrophil count decreased on Mar 26, 2008 from JAPAN Additional patient health information: Male patient , weighting 119.0 lb, was diagnosed with non-small cell lung cancer, asthma (What is asthma?) and. Campto dosage: Daily Dose:156mg. During the same period patient was treated with GEMZAR (Daily Dose:1560mg) (View Gemzar Review and Gemzar Label ), FLUTIDE (View Flutide Review and Flutide Label ), SEREVENT (View Serevent Review and Serevent Label ), SULTANOL (View Sultanol Review and Sultanol Label ).

5696388-4 | Blood Potassium Increased, Neutrophil Count Decreased
Adverse event was reported on Mar 26, 2008 by a Male patient taking Campto (View Usage) (Dosage: Daily Dose:156mg) was diagnosed with non-small cell lung cancer, asthma (What is asthma?) and. Location: JAPAN , weighting 119.0 lb, After Campto was administered, patient had the following side effects: blood potassium increased, neutrophil count decreased. During the same period patient was treated with GEMZAR (Daily Dose:1560mg) (View Gemzar Review and Gemzar Label ), FLUTIDE (View Flutide Review and Flutide Label ), SEREVENT (View Serevent Review and Serevent Label ), SULTANOL (View Sultanol Review and Sultanol Label ).

5693906-7 | Dysuria, Haemoglobin Decreased, Leukopenia, Neutropenia, Urinary Retention
on Mar 24, 2008 Female patient from JAPAN , weighting 101.4 lb, was diagnosed with non-small cell lung cancer, dizziness (What is dizziness?), cancer pain, laxative supportive care, hypertension and was treated with Campto (View Usage). Patient experienced the following unwanted or unexpected effects: dysuria, haemoglobin decreased, leukopenia, neutropenia, urinary retention. Campto dosage: . During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), DESYREL (Daily Dose:50mg) (View Desyrel Review and Desyrel Label ), TRAVELMIN (Text:1 Df) (View Travelmin Review and Travelmin Label ), CEPHADOL (View Cephadol Review and Cephadol Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), NORVASC (View Norvasc Review and Norvasc Label ), BLOPRESS (View Blopress Review and Blopress Label ).

5685516-2 | Blood Creatinine Increased, Blood Potassium Decreased, Blood Urea Increased, Haemoglobin Decreased, Neutrophil Count Decreased, Renal Failure, White Blood Cell Count Decreased
on Mar 17, 2008 Male patient from JAPAN , weighting 110.2 lb, was diagnosed with non-small cell lung cancer, hypertension and was treated with Campto (View Usage). Patient had the following side effects: blood creatinine increased, blood potassium decreased, blood urea increased, haemoglobin decreased, neutrophil count decreased, renal failure, white blood cell count decreased. Campto dosage: Daily Dose:73mg. During the same period patient was treated with PACLITAXEL (Daily Dose:262.8mg) (View Paclitaxel Review and Paclitaxel Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), CONIEL (View Coniel Review and Coniel Label ).

5662351-2 | Gastric Perforation
Patient was taking Campto (View Usage). After Campto was administered, patient had the following side effects: gastric perforation on Feb 26, 2008 from JAPAN Additional patient health information: Male patient , 74 years of age, was diagnosed with gastric cancer and. Campto dosage: Daily Dose:25mg/m2. During the same period patient was treated with TEGAFUR/GIMERACIL/OTERACIL POTASSIUM (Daily Dose:60mg/m2) (View Tegafur/gimeracil/oteracil Potassium Review and Tegafur/gimeracil/oteracil Potassium Label ), CISPLATIN (Daily Dose:15mg/m2) (View Cisplatin Review and Cisplatin Label ).

5662342-1 | Cardiac Failure
Adverse event was reported on Mar 04, 2008 by a Male patient taking Campto (View Usage) (Dosage: ) was diagnosed with colorectal cancer metastatic and. Location: FRANCE , 45 years of age, Patient experienced the following unwanted or unexpected effects: cardiac failure. During the same period patient was treated with CETUXIMAB (View Cetuximab Review and Cetuximab Label ).

5654100-9 | Gastric Perforation
on Feb 26, 2008 Male patient from , 74 years of age, was diagnosed with gastric cancer and was treated with Campto (View Usage). Patient had the following side effects: gastric perforation. Campto dosage: Daily Dose:25mg/m2. During the same period patient was treated with TEGAFUR/GIMERACIL/OTERACIL POTASSIUM (Daily Dose:60mg/m2) (View Tegafur/gimeracil/oteracil Potassium Review and Tegafur/gimeracil/oteracil Potassium Label ), CISPLATIN (Daily Dose:15mg/m2) (View Cisplatin Review and Cisplatin Label ).

5614276-6 | Deafness
on Jan 29, 2008 Female patient from GERMANY , weighting 141.1 lb, was diagnosed with small intestine carcinoma and was treated with Campto (View Usage). After Campto was administered, patient had the following side effects: deafness. Campto dosage: . During the same period patient was treated with FOLINIC ACID (View Folinic Acid Review and Folinic Acid Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ).

5613027-9 | Chest Discomfort, Dyspnoea, Subacute Endocarditis, Tachycardia
Patient was taking Campto (View Usage). Patient experienced the following unwanted or unexpected effects: chest discomfort, dyspnoea, subacute endocarditis, tachycardia on Jan 29, 2008 from GERMANY Additional patient health information: Male patient , weighting 180.8 lb, was diagnosed with colon cancer metastatic and. Campto dosage: Daily Dose:80mg/m2. During the same period patient was treated with AVASTIN (Daily Dose:400mg) (View Avastin Review and Avastin Label ), FLUOROURACIL (Text:2 G/m2) (View Fluorouracil Review and Fluorouracil Label ), SODIUM FOLINATE (View Sodium Folinate Review and Sodium Folinate Label ). Patient was hospitalized.

5607120-4 | Chest Discomfort, Dyspnoea, Subacute Endocarditis, Tachycardia
Adverse event was reported on Jan 22, 2008 by a Male patient taking Campto (View Usage) (Dosage: Daily Dose:80mg/m2) was diagnosed with colon cancer metastatic and. Location: GERMANY , weighting 180.8 lb, Patient had the following side effects: chest discomfort, dyspnoea, subacute endocarditis, tachycardia. During the same period patient was treated with AVASTIN (Daily Dose:400mg) (View Avastin Review and Avastin Label ), FLUOROURACIL (Text:2 G/m2) (View Fluorouracil Review and Fluorouracil Label ), SODIUM FOLINATE (View Sodium Folinate Review and Sodium Folinate Label ). Patient was hospitalized.

5599367-0 | Blood Bilirubin Increased, Disseminated Intravascular Coagulation, Febrile Neutropenia, Leukopenia, Pneumonia Bacterial, Septic Shock, Thrombocytopenia
on Jan 09, 2008 Male patient from JAPAN , weighting 125.7 lb, was diagnosed with large intestine carcinoma, fluid replacement, vomiting, antipyresis, dry mouth and was treated with Campto (View Usage). After Campto was administered, patient had the following side effects: blood bilirubin increased, disseminated intravascular coagulation, febrile neutropenia, leukopenia, pneumonia bacterial, septic shock, thrombocytopenia. Campto dosage: Daily Dose:150mg/m2. During the same period patient was treated with VITAMIN B COMPLEX CAP (Text:1 Df) (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ), PRIMPERAN INJ (Daily Dose:10mg) (View Primperan Inj Review and Primperan Inj Label ), POTACOL R (Daily Dose:500ml) (View Potacol-r Review and Potacol-r Label ), AMINO ACIDS/CARBOHYDRATES/MINERALS/VITAMINS, (Text:1l) (View Amino Acids/carbohydrates/minerals/vitamins, Review and Amino Acids/carbohydrates/minerals/vitamins, Label ), LACTEC (View Lactec Review and Lactec Label ), ROPION (Daily Dose:50mg) (View Ropion Review and Ropion Label ), POTASSIUM PHOSPHATE DIBASIC (View Potassium Phosphate Dibasic Review and Potassium Phosphate Dibasic Label ).

5587242-7 | Dyspnoea, Interstitial Lung Disease, Skin Reaction
on Jan 04, 2008 Female patient from GERMANY , weighting 156.5 lb, was diagnosed with colon cancer metastatic and was treated with Campto (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, interstitial lung disease, skin reaction. Campto dosage: . During the same period patient was treated with CETUXIMAB (View Cetuximab Review and Cetuximab Label ), DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ), ATROPIN (View Atropin Review and Atropin Label ).

5573795-1 | Diarrhoea, Leukopenia, Neutropenia, Shock
Patient was taking Campto (View Usage). Patient had the following side effects: diarrhoea, leukopenia, neutropenia, shock on Dec 14, 2007 from JAPAN Additional patient health information: Female patient , weighting 105.8 lb, was diagnosed with non-small cell lung cancer, abdominal pain (What is abdominal pain?), abdominal distension and. Campto dosage: Daily Dose:20mg. During the same period patient was treated with CRAVIT (Text:1df) (View Cravit Review and Cravit Label ), PANSPORIN (Daily Dose:2gram) (View Pansporin Review and Pansporin Label ), PRIMPERAN INJ (Text:1df) (View Primperan Inj Review and Primperan Inj Label ), BUSCOPAN (Text:1df) (View Buscopan Review and Buscopan Label ).

5572542-7 | Pulmonary Embolism
Adverse event was reported on Dec 11, 2007 by a Female patient taking Campto (View Usage) (Dosage: Daily Dose:80mg) was diagnosed with gastric cancer and. Location: JAPAN , weighting 110.2 lb, After Campto was administered, patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with TEGAFUR/GIMERACIL/OTERACIL POTASSIUM (View Tegafur/gimeracil/oteracil Potassium Review and Tegafur/gimeracil/oteracil Potassium Label ).

5546884-5 | Colitis, Diarrhoea, Disseminated Intravascular Coagulation, Febrile Neutropenia, Haemoglobin Decreased, Leukopenia, Thrombocytopenia
on Nov 29, 2007 Female patient from JAPAN , weighting 114.6 lb, was diagnosed with cervix carcinoma and was treated with Campto (View Usage). Patient experienced the following unwanted or unexpected effects: colitis, diarrhoea, disseminated intravascular coagulation, febrile neutropenia, haemoglobin decreased, leukopenia, thrombocytopenia. Campto dosage: . During the same period patient was treated with NEDAPLATIN (View Nedaplatin Review and Nedaplatin Label ), KYTRIL (View Kytril Review and Kytril Label ), DECADRON (View Decadron Review and Decadron Label ).